Cancer diagnostics News and Research

RSS

University of Michigan offers new test to improve PSA screening for prostate cancer

More than 1 million men will undergo a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.

26 Sep 2013

New And Improved Method For Analyzing Single-Cell Gene Expression

...

24 Sep 2013

Depression in cancer patients who receive RT can be identified by 2-item questionnaire

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Researchers develop new, improved technique for single-cell gene expression analysis

A team of researchers affiliated with Ludwig Cancer Research and the Karolinska Institutet in Sweden report in the current issue of Nature Methods a dramatically improved technique for analyzing the genes expressed within a single cell -- a capability of relevance to everything from basic research to future cancer diagn

23 Sep 2013

ASTRO to honor Atlanta resident and cancer survivor with 2013 Survivor Circle Award

The American Society for Radiation Oncology has selected Atlanta resident and cancer survivor Sherri Graves Smith to receive the 2013 Survivor Circle Award.

19 Sep 2013

Different types of narratives have different effects on patients' health decision-making processes

Individuals often turn to others for advice when making choices. Perhaps, it seems fitting then, that individuals would seek out others when they are faced with important health decisions.

19 Sep 2013

Study reports identification of IDH1 protein as novel biomarker for diagnosis of NSCLC

A protein called isocitrate dehydrogenase is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

17 Sep 2013

New "app" from Henry Ford for cancer surgery patients

With a single tap on a smartphone, cancer patients now can access detailed information about treatment options by cancer type, GPS mapping to appointment locations, as well as schedule appointments and connect to their electronic medical record.

17 Sep 2013

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

The American Society for Radiation Oncology (ASTRO) praises the "Delivering High-Quality Cancer Care: Charting a News Course for a System in Crisis" report, issued earlier today by the Institute of Medicine (IOM) of the National Academies.

12 Sep 2013

T-rays are ideal for detecting early signs of melanoma

The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist said here today.

12 Sep 2013

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

They say a phone call can change your life and for colorectal or bowel cancer survivors this is true, a new study by a QUT researcher has found.

12 Sep 2013

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

...

3 Sep 2013

Novel metabolic imaging method enhances prostate cancer diagnosis

Metabolic imaging with hyperpolarized pyruvate is a noninvasive and well-tolerated method for visualizing prostate tumors, US scientists have shown.

2 Sep 2013

Researchers develop low-cost technology to detect cancer

While many college football fans are focused on this week's marquee matchup between the Georgia Bulldogs and the Clemson Tigers, researchers from the two institutions are working together off the playing field to develop low-cost technology that can detect cancer.

28 Aug 2013

Bioactive compounds in coffee may prevent prostate cancer recurrence, delay progression

Coffee consumption is associated with a lower risk of prostate cancer recurrence and progression, according to a new study by Fred Hutchinson Cancer Research Center scientists that is online ahead of print in Cancer Causes & Control.

27 Aug 2013

Study examines risk of all types of cancer in relatives of children with cancer

When a child is diagnosed with cancer, one of the first questions the parents ask is "Will my other children get cancer?" A new study from Huntsman Cancer Institute at the University of Utah suggests the answer to that question depends on whether a family history of cancer exists. The research results were published online in the International Journal of Cancer and will appear in the November 15 print issue.

8 Aug 2013

Study could boost development of personalised medicine in cancer care and therapy

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. Having the means to identify patients who are most likely to benefit from currently available cancer drugs not only reduces substantially the healthcare cost for the patient, it could mean saving precious lives by getting the right drugs to the right patient at the onset of the treatment.

7 Aug 2013

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs.

7 Aug 2013

Study finds cancer survivors do not always have best access to primary care

While cancer survivors require follow-up care to prevent a recurrence of their cancer and to watch for after effects of treatment, they also need the same preventive check-ups suggested for all people.

7 Aug 2013

NanoString announces Early Access Program for nCounter Elements used in translational research

NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories.

From NanoString Technologies 2 Aug 2013

Cancer diagnostics News and Research

University of Michigan offers new test to improve PSA screening for prostate cancer

New And Improved Method For Analyzing Single-Cell Gene Expression

Depression in cancer patients who receive RT can be identified by 2-item questionnaire

Researchers develop new, improved technique for single-cell gene expression analysis

ASTRO to honor Atlanta resident and cancer survivor with 2013 Survivor Circle Award

Different types of narratives have different effects on patients' health decision-making processes

Study reports identification of IDH1 protein as novel biomarker for diagnosis of NSCLC

New "app" from Henry Ford for cancer surgery patients

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

T-rays are ideal for detecting early signs of melanoma

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

Novel metabolic imaging method enhances prostate cancer diagnosis

Researchers develop low-cost technology to detect cancer

Bioactive compounds in coffee may prevent prostate cancer recurrence, delay progression

Study examines risk of all types of cancer in relatives of children with cancer

Study could boost development of personalised medicine in cancer care and therapy

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

Study finds cancer survivors do not always have best access to primary care

NanoString announces Early Access Program for nCounter Elements used in translational research

Cancer Research - Second Edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News